Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia

PURPOSE: To examine the impact of newly initiated pregabalin or duloxetine treatment on fibromyalgia (FM) patients’ encounters with potential drug–drug interactions (DDIs), the health care cost and utilization consequences of those interactions, and the impact of treatment on opioid utilization. PAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Jeffrey J, Sadosky, Alesia B, Ten Eyck, Laura L, Cappelleri, Joseph C, Brown, Courtney R, Suehs, Brandon T, Parsons, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204911/
https://www.ncbi.nlm.nih.gov/pubmed/25339847
http://dx.doi.org/10.2147/CEOR.S66759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204911/
https://www.ncbi.nlm.nih.gov/pubmed/25339847
http://dx.doi.org/10.2147/CEOR.S66759

Ejemplares similares